These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 195035)

  • 21. Re-evaluation of dosage and duration of action of d-tubocurarine in the pediatric age group.
    Goudsouzian NG; Donlon JV; Savarese JJ; Ryan JF
    Anesthesiology; 1975 Oct; 43(4):416-25. PubMed ID: 170845
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effects of small incremental doses of d-tubocurarine on neuromuscular transmission in anesthetized man.
    Heisterkamp DV; Skovsted P; Cohen PJ
    Anesthesiology; 1969 May; 30(5):500-5. PubMed ID: 4305093
    [No Abstract]   [Full Text] [Related]  

  • 23. Interaction of verapamil with d-tubocurarine and cholinergic agonists at the avian neuromuscular junction.
    Wali FA
    Acta Anaesthesiol Scand; 1987 Jan; 31(1):15-20. PubMed ID: 3030036
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardiovascular and neuromuscular effects of dimethyl tubocurarine in anaesthetized cats and rhesus monkeys.
    Hughes R; Chapple DJ
    Br J Anaesth; 1976 Sep; 48(9):847-52. PubMed ID: 183800
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Time-dependent increase in sensitivity to d-tubocurarine during enflurane anesthesia in man.
    Stanski DR; Ham J; Miller RD; Sheiner LB
    Anesthesiology; 1980 Jun; 52(6):483-7. PubMed ID: 7377594
    [No Abstract]   [Full Text] [Related]  

  • 26. Pharmacokinetics of tubocurarine administered by combined i.v. bolus and infusion.
    Ramzan MI; Shanks CA; Triggs EJ
    Br J Anaesth; 1980 Sep; 52(9):893-9. PubMed ID: 7437228
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Early and late relative potencies of pancuronium and d-tubocurarine in man.
    Miller RD; Eger EI
    Anesthesiology; 1976 Apr; 44(4):297-300. PubMed ID: 1259187
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical pharmacokinetics and pharmacodynamics of fazadinium in renal failure.
    Bevan DR; D'Souza JD; Rouse JM; Caldwell J; Smith RL
    Eur J Clin Pharmacol; 1981; 20(4):293-8. PubMed ID: 6118278
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics: the scientific basis for drug selection.
    Longnecker DE
    Anesth Analg; 1978; 57(6):603-4. PubMed ID: 216286
    [No Abstract]   [Full Text] [Related]  

  • 30. Renal function and the pharmacokinetics of neostigmine in anesthetized man.
    Cronnelly R; Stanski DR; Miller RD; Sheiner LB; Sohn YJ
    Anesthesiology; 1979 Sep; 51(3):222-6. PubMed ID: 382915
    [No Abstract]   [Full Text] [Related]  

  • 31. Prolonged neuromuscular blockade with pancuronium in the presence of acute renal failure: a case report.
    Geha DG; Blitt CD; Moon BJ
    Anesth Analg; 1976; 55(3):343-5. PubMed ID: 945014
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative potency and speed of onset of fazadinium and d-tubocurarine.
    Hussain SZ; Healy TE; Birmingham AT
    Acta Anaesthesiol Scand; 1979 Aug; 23(4):331-5. PubMed ID: 40380
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of non-paralytic doses of D-tubocurarine on individual motor end-plates in man, studied with a new electrophysiological method.
    Ekstedt J; Stålberg E
    Electroencephalogr Clin Neurophysiol; 1969 Dec; 27(6):557-62. PubMed ID: 4188779
    [No Abstract]   [Full Text] [Related]  

  • 34. Tubocurarine and renal failure.
    Gibaldi M; Levy G; Hayton WL
    Br J Anaesth; 1972 Feb; 44(2):163-5. PubMed ID: 5016882
    [No Abstract]   [Full Text] [Related]  

  • 35. Reduced neuromuscular transmission safety factor in multiple sclerosis.
    Eisen A; Yufe R; Trop D; Campbell I
    Neurology; 1978 Jun; 28(6):598-602. PubMed ID: 206859
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetics and pharmacodynamics of d-tubocurarine in infants, children, and adults.
    Fisher DM; O'Keeffe C; Stanski DR; Cronnelly R; Miller RD; Gregory GA
    Anesthesiology; 1982 Sep; 57(3):203-8. PubMed ID: 7114542
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetics and pharmacodynamics of metocurine in humans with and without renal failure.
    Brotherton WP; Matteo RS
    Anesthesiology; 1981 Sep; 55(3):273-6. PubMed ID: 7023284
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of sodium nitroprusside on the biophase concentration of D-tubocurarine at the neuromuscular junction.
    Chang P; Geh SL
    Clin Exp Pharmacol Physiol; 1986 May; 13(5):433-6. PubMed ID: 3742886
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacodynamics and pharmacokinetics of metocurine in humans: comparison to d-tubocurarine.
    Matteo RS; Brotherton WP; Nishitateno K; Khambatta HJ; Dias J
    Anesthesiology; 1982 Sep; 57(3):183-90. PubMed ID: 6287887
    [No Abstract]   [Full Text] [Related]  

  • 40. Studies of d-tubocurarine pharmacokinetics in humans and dogs.
    Ramzan IM; Shanks CA; Triggs EJ
    Anaesth Intensive Care; 1978 Feb; 6(1):30-5. PubMed ID: 665974
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.